retatrutide and ghk-cu Research Peptide Bundle GHK-Cu 50mg recherche in vitro

When administered into the brain circulation and cerebrospinal fluid of mice, DSIP showed a significant, dose-dependent reduction in pain response in the tail-pinch and hot-plate tests

Trigger point injections are most commonly recommended for patients who have neck or back pain associated with muscle spasm, with or without an underlying spinal condition

USA-crafted without thickeners, waxes, fragrances, or fillers, this formula features GHK-Cu in a plant-based HA blend delivering superior results that outperform diluted alternatives

Typical Protocol: Loading Phase: 2.02.5 mg, 2-3 times per week for 4-6 weeks